The business's fifty day moving average is $79.03 and its 200 day moving average is $99.15. News. About GLPG. This share price information is delayed by 15 minutes. Globe Newswire. The firm has a market capitalization of $5.19 billion, a price-to-earnings ratio of -11.99 and a beta of 0.76. About Market Cap. 2021/05/07 03:08 UTC. The company's market cap has fallen to around $5.6 billion at recent prices, even though the company has around $6.3 billion in cash plus $3.4 billion in deferred revenue on its balance sheet. Galapagos has a 52 week low of $74.51 and a 52 week high of $233.14. Our pipeline comprises discovery through Phase 3 programs in inflammation, fibrosis and other indications. The price will be heading $240 soon. €4.1b. Press releases . This multiple is used to compare a company's market value with its earnings. (NASDAQ: GLPG) Galapagos Nv's market cap is $5.03B, as of May 6, 2021. Galapagos has a 52 week low of $74.51 and a 52 week high of $233.14. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. The enterprise value is -$1.53 billion. The company develops drugs against rheumatoid arthritis, crohn's disease, … Cup and Handle formation. Galapagos NV discovers, develops and commercializes small molecule medicines with novel modes of action, several of which show promising patient results and are currently in late-stage development in multiple diseases. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium. Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. The RSI / MACD and volume showing signs of recovery from recent 60% correction. Market Cap. Galapagos has a 12-month low of $70.77 and a 12-month high of $227.71. The CEO is the Dutchman Onno van de Stolpe. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. Instrument market cap (£m) -Earnings per share -Issue date . Market cap: 5.208B: Beta (5Y monthly) 0.28: PE ratio (TTM) N/A: EPS (TTM)-1.69: Earnings date: N/A: Forward dividend & yield: N/A (N/A) Ex-dividend date: N/A: 1y target est: 93.67: All. Its headquarters are located in Mechelen and has additional locations in Leiden, Romainville, Basel, Milan, Madrid, Boston and Zagreb. To calculate GALAPAGOS's market, we take the total number of its shares issued and multiply it by GALAPAGOS's current market price. More Details. The subscription rights as such will not be listed on any stock market. Galapagos market cap is €4.4 b, and annual revenue was €478.05 m in FY 2020. 74,481. Market Cap 4,915.99M; Shares Out 65.51M; 10 Day Average Volume 0.27M; Dividend-Dividend Yield-Beta 0.45; YTD % Change-24.19; Show Ratios / Profitability & Events . It operates through the Research & Development and Fee-for-Services segment. The firm's fifty day moving average is $79.80 and its 200 day moving average is $101.51. Find the latest GALAPAGOS (GLPG.AS) stock quote, history, news and other vital information to help you with your stock trading and investing. As of 19/03/21, shares in Galapagos NV are trading at $82.19, giving the company a market capitalisation of £3.84bn. Risk Analysis. Trading at 67.5% below our estimate of its fair value. Galapagos NV is a European pharmaceutical research company which was founded in 1999. Galapagos has a market cap of $5.16 B, which represents its current share price of $78.75 multiplied by its outstanding share number of 65.51. Galapagos NV is a biotechnology company, which … At the stock price of $123.68, Galapagos had a market capitalization of about $8.1 billion. Turnover (on book) -Display price followed by previous trading day date . Get detailed information on Galapagos NV Tokenized Stock (GLPG.cx) including real-time price index, historical charts, market cap, exchanges, wallets, and latest news. The stock has a fifty day moving average of $80.50 and a 200 day moving average of $105.57. Instrument information What's this? Data Sources. Market Cap (MIL) 4,096.44: Forward P/E-14.08: Dividend (Yield %)--Advanced Charting. Galapagos NV, a clinical-stage biotechnology company, discovers, develops, and commercializes various small molecule medicines. The next estimated earnings date is August 5, 2021, which is a Thursday. The company has a Price to Book ratio of 2.69. The Company is focused on the discovery and development of small molecule medicines with novel modes of action. Estimated Earnings Date: Aug 5, 2021: Ex-Dividend Date: n/a: Share Statistics. Rewards. GLPG Could be a Takeover Target GLPG has now morphed from a stock market darling to a near pariah as its market cap is now less than the cash on its balance sheet. Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares. Open price -Previous close price / date - / - Volume . A company with a high P/Earnings NTM is considered to … GALAPAGOS ORD SHS: 69.13. Market Cap is calculated by multiplying the number of shares outstanding by the stock's price. GLPG has a market cap of $5.34bn and a cash balance of $6.4bn, which, given its small $35mn debt, gives it a net enterprise value of ($944mn). The firm has a market cap of $5.16 billion, a P/E ratio of -11.93 and a beta of 0.76. Galapagos has a market cap or net worth of $4.73 billion. What happened. View Galapagos stock / share price, financial statements, key ratios and more at Craft. Market capitalization usually refers to the total value of a company's stock within the entire market. Galapagos’ market cap is currently $8B and has a P/E ratio of 83.40. Galapagos has 65.51 million shares outstanding. Highly volatile share price over … OTHERS. 1.60%: Equity-As at 23.04.21 02:00:41 - All data delayed at least 15 minutes . We think Galapagos is undervalued at current levels. … The number of shares has … The company has a market cap of $4.99 billion, a price-to-earnings ratio of -11.54 and a beta of 0.76. 10 February … Hedge funds have recently modified their holdings of the stock. P/E relates the current share price with the market expectations in terms of Earnings Per Share. ET by Sara Sjolin 5 things to know about biotech Denali Therapeutics and its $250 million IPO Last Updated. Some revenue growth going forward is assumed in that market cap. The stock has a market cap of $4.92 billion, a price-to-earnings ratio of -11.37 and a beta of 0.76. Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. For companies with multiple common share classes, market capitalization includes both classes. Market Cap: 4.73B: Enterprise Value-1.53B: Important Dates. Mechelen, Belgium; 3 March 2021; 22.15 CET; regulated information – Galapagos NV (Euronext & NASDAQ: GLPG) … Price information What's this? Galapagos NV is a Belgium-based clinical-stage biotechnology company. Next Event . Galapagos has a twelve month low of $73.81 and a twelve month high of $233.14. Galapagos Nv 's market cap is calculated by multiplying GLPG 's current stock price of $77.77 by GLPG 's total outstanding shares of 64,666,802 . For companies with multiple common share classes, market capitalization includes both classes. TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. Galapagos NV (formerly known as Galapagos Genomics) is a European pharmaceutical research company which was founded in 1999. Galapagos climbs 5.4% after exercising co-promotion option with Gilead Dec. 15, 2017 at 3:17 a.m. Executive Summary. Market multiple valuation of Galapagos NV ( GLPG | BEL) The most common multiple used in the valuation of stocks is the P/Earnings NTM multiple (Price to Earnings). Market . See which 3 stocks are most likely to make moves following their insider activities. The stock has a 50 day simple moving average of $78.17 and a 200-day simple moving average of $97.32. Our ambition is to become a leading global biotech … About Galapagos This share price information is delayed by 15 minutes. Company Financials + 15 Analysts. Total Market Cap: M. Cap: $ 2.12T (4.6%) BTC Dominance: BTC DOM: 48.62% (-0.8%) Total Volume: 24H VOL: $ 412.80B (-12.8%) BTC Price: BTC: $ 55,168 (2.8%) ETH Gas: $ 2.90 (52 Gwei) Slow . Shares of Galapagos (NASDAQ:GLPG) were crashing 24.6% lower as of 11:14 a.m. EDT on Wednesday. Transparency notification received from The Capital Group. Its clinical stage programs include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative colitis, small bowel CD, fistulizing CD, Sjögren's syndrome, ankylosing spondylitis, … EUR.
Multi Strategy Hedge Funds,
Barrow Vs Exeter Results,
Burnley V Sheffield United Head To Head,
Hofstra Men's Lacrosse Schedule 2021,
Case Worker Salary Nyc,